• Profile
Close

Circulating osteoprotegerin in postmenopausal osteoporotic women: Marker of impaired glucose regulation or impaired bone metabolism

Menopause Nov 02, 2017

Mashavi M, et al. - The relationship of osteoprotegerin (OPG) to glucose homeostasis and insulin resistance in postmenopausal osteoporotic women with different types of glucose tolerance is researched in this study. Based on these outcomes, OPG is significantly higher in postmenopausal osteoporotic women with impaired glucose regulation (IGT and DM) than women with normal glucose tolerance (NGT). OPG was independently related to insulin resistance evaluated by Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Thus, measurement of OPG may potentially be considered as a prediabetic state screening in postmenopausal osteoporotic women.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay